Problem

Remedial Health addresses the fragmented and inefficient pharmaceutical supply chain serving African pharmacies, hospitals, and proprietary patent medicine vendors. In Nigeria, many pharmacies procure medicines through open-air markets and multiple intermediaries, exposing them to high prices, counterfeit products, unreliable availability, and a heavy administrative burden. The economics are especially painful because medicines are expensive relative to household purchasing power: one investment source cites average monthly household income of about $165 versus essential prescriptions costing as much as $20.

The clearest use case is a neighborhood pharmacy that needs to keep essential medicines on its shelves but cannot afford to tie up scarce cash in inventory or risk buying counterfeits. Remedial Health combines trusted sourcing with inventory finance so the pharmacy can obtain genuine stock quickly, pay after dispensing it, and avoid a cash-flow crunch that would otherwise limit sales and patient access.

Product / Service

Remedial Health is a technology-enabled B2B pharmaceutical procurement and pharmacy-operations platform. Its managed marketplace and digital store connect healthcare providers with medicines, medical consumables, and devices sourced from manufacturers or vetted distributors. Customers can consolidate purchasing in one place, access more than 5,000 products, receive delivery within 24 hours, and use anti-counterfeit controls and manufacturer relationships to improve authenticity and pricing.

The platform also includes Remedial Rx, which manages pharmacy employees, sales, accounting, patient medication records, inventory, prescription validation, and automatic replenishment. Its Buy Now, Pay Later product lets a pharmacy request financing in the app, receive approval, purchase through the Remedial Store, receive stock, and pay later after dispensing to patients. Additional offerings provide pharmacy-benefit services for insurers and HMOs, pharmaceutical market intelligence, and market-access support for manufacturers. The benefit is a single operating layer that reduces procurement friction, improves working-capital efficiency, and helps providers serve patients more reliably.

Market

Remedial Health competes at the intersection of African healthtech, B2B pharmaceutical e-commerce, pharmacy-management software, supply-chain technology, and embedded healthcare finance. Its initial market is Nigeria, with an expansion ambition across Africa; Y Combinator describes the addressable customer base as roughly one million pharmacies and hospitals on the continent. Comparable or adjacent competitors identified in market databases include DrugStoc and Axmed, while broader alternatives include Vittas, Medplus, and Field.

The company is operating commercially rather than appearing pre-revenue. Its website reports more than 10,000 pharmacies, patent stores, hospitals, and HMOs served, while a 2023 investor account reported more than 5,000 hospitals, pharmacies, and PPMVs across 34 Nigerian states and described significant revenue and ARR growth. Remedial Health also raised a $12 million equity-and-debt round, comprising an $8 million Series A and $4 million of debt, to scale its operations; its traction and financing indicate a growing distribution and fintech platform rather than an early pre-revenue experiment.